Thanks Spinefx,I wont buy into it I will wait since winter is...

First 205 Last

Share
Profile

Follow
cashngrab

4,881 Posts.

5

14/03/19

22:59

Post #: 37768054
Share

Originally posted by spinefx: ↑

Cash,

Winx is done. The expensive winter drilling has been expensed.

There is no more exploration costed in the short term.

Icewine side track is possible, but not with our current cash balance as that would expose us at this time. I really don't see us doing any further unconventional drilling, sans PB, I think that will be handled by others, if at all. It's beyond our capabilities and I'm happy to have others do it, if we can retain a portion, well done.

Summer is the best time for that to be looked at anyway. No Tundra time frames there, only the seasons, the permit probably just needs to be updated.

Yukon is at least next winter season away. Again though, expensive winter drilling. Plenty going on in this area so could be a smoky.

Charlie or Bravo, can't see us going alone, with ice roads, drilling, testing. That would be $15-20 mill, at a guess, beyond us. We have new seismic and some legacy well data but that had its own limitations, as we now know.

I really have no idea but can't see any need before next winter, so a late summer CR, best watch to see if Dave does a Investor Presentation in London that's a given for a CR within the following fortnight.

Obviously a lot hinges on a potential Farm-out, whatever structure that takes, I for one will breathe a little easier.

On a side note, was thinking today about Horseshoe and how the well data hasn't been released, any clay over they guys? Or if the structure on the pinch out is prone to this.

Anywho, bit late for this rambling.

Cheers

Expand

Thanks Spinefx,

I wont buy into it I will wait since winter is over and they need to shut up shop soon, thanks for your comments.
I cant see 88e doing much now I think the SP will stagnate

Last edited by cashngrab: 14/03/19

88E Price at posting: 1.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

HAW

Hastings progressing Yangibana to production with lower costs

ZNO

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

TI1

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The iron ore comeback: Can it last?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 160 more messages in this thread...

First 205 Last

Add 88E (ASX) to my watchlist

(20min delay)
Last 0.3¢		Change 0.001(25.0%)		Mkt cap ! $57.86M

Open	High	Low	Value	Volume
0.2¢	0.3¢	0.2¢	$5.805K	2.894M

Buyers (Bids)

No.	Vol.	Price($)
93	109415193	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	566213746	229

View Market Depth

No.	Vol.	Price($)
392	1227558997	0.001
0	0	0.000
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.002	5375412	5
0.003	578667432	226
0.004	223019047	110
0.005	59085042	48
0.006	35128234	35

Last trade - 15.43pm 30/09/2024 (20 minute delay)

88E (ASX) Chart

Thanks Spinefx,I wont buy into it I will wait since winter is...

Hastings progressing Yangibana to production with lower costs

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The iron ore comeback: Can it last?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks Spinefx,I wont buy into it I will wait since winter is...

Top Stories

Hastings progressing Yangibana to production with lower costs

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The iron ore comeback: Can it last?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News